{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:10:07Z","timestamp":1792469407295,"version":"4.5.0"},"reference-count":39,"publisher":"Massachusetts Medical Society","issue":"12","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann La-Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2018,3,22]]},"DOI":"10.1056\/nejmoa1713976","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T17:01:06Z","timestamp":1521651666000},"page":"1107-1120","source":"Crossref","is-referenced-by-count":868,"title":["Venetoclax\u2013Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia"],"prefix":"10.1056","volume":"378","author":[{"given":"John F.","family":"Seymour","sequence":"first","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Eichhorst","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hillmen","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"D\u2019Rozario","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Assouline","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Owen","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gerecitano","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Robak","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"De la Serna","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Jaeger","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cartron","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montillo","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Humerickhouse","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Punnoose","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Boyer","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Humphrey","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mobasher","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon P.","family":"Kater","sequence":"additional","affiliation":[{"name":"From the Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC (J.F.S.), and the John Curtin School of Medical Research, Australian National University, Canberra, ACT (J.D.) \u2014 all in Australia; the University of California School of Medicine, San Diego (T.J.K.), and Genentech, South San Francisco (E.A.P., Y.L., M. Mobasher) \u2014 both in California; University Hospital Cologne and the Center for Integrated Oncology Cologne\u2013Bonn, Cologne, Germany (B.E.); St...."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.8061"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70335-3"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509981"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315226"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30671-4"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00465-9"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1011641"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.07.001"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506654102"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28281"},{"key":"e_1_3_5_13_2","first-page":"456","article-title":"Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome.","volume":"10","author":"Robertson LE","year":"1996","unstructured":"Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 1996;10:456-459.8642861","journal-title":"Leukemia"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-688796"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30019-5"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513257"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1258"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61381-5"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25853"},{"issue":"8","key":"e_1_3_5_21_2","first-page":"e302","article-title":"Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors.","volume":"100","author":"Thijssen R","year":"2015","unstructured":"Thijssen R, Slinger E, Weller K, et al. Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors. Haematologica 2015;100(8):e302-e306.25957396","journal-title":"Haematologica"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30012-8"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-714162"},{"key":"e_1_3_5_24_2","first-page":"3758","volume-title":"J Clin Oncol","author":"Kovacs G","year":"2016","unstructured":"Kovacs G, Robrecht S, Fink AM, et al. Minimal residual disease assessment improves prediction of outcome in patients with chronic lymphocytic leukemia (CLL) who achieve partial response: comprehensive analysis of two phase III studies of the German CLL Study Group. J Clin Oncol 2016;34:3758-3765. 27573660"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.9348"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.720.720"},{"key":"e_1_3_5_27_2","unstructured":"Hallek M. Presentation and discussion of revised iwCLL guidelines for the approach to a CLL patient. Presented at the XVII International Workshop on Chronic Lymphocytic Leukemia New York May 12\u201315 2017."},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.002"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv303"},{"key":"e_1_3_5_30_2","unstructured":"National Comprehensive Cancer Network. NCCN guidelines: chronic lymphocytic leukemia\/small lymphocytic lymphoma. Version 2.2017. February 21 2017 (https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp)."},{"key":"e_1_3_5_31_2","first-page":"231","article-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use.","volume":"48","year":"1997","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use. Int Dig Health Legis 1997;48:231-234.11656783","journal-title":"Int Dig Health Legis"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.25"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-3758(01)00077-5"},{"key":"e_1_3_5_37_2","first-page":"421","volume-title":"Hematol Am Soc Hematol Educ Program","author":"Shanafelt TD","year":"2009","unstructured":"Shanafelt TD. Predicting clinical outcome in CLL: how and why. Hematol Am Soc Hematol Educ Program 2009;1:421-429.20008228"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.4556"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa4642"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.7528"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1713976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:50:35Z","timestamp":1711486235000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1713976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,3,22]]}},"alternative-id":["10.1056\/NEJMoa1713976"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1713976","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732882883.793582419","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]}}}